JP2006512364A5 - - Google Patents

Download PDF

Info

Publication number
JP2006512364A5
JP2006512364A5 JP2004562206A JP2004562206A JP2006512364A5 JP 2006512364 A5 JP2006512364 A5 JP 2006512364A5 JP 2004562206 A JP2004562206 A JP 2004562206A JP 2004562206 A JP2004562206 A JP 2004562206A JP 2006512364 A5 JP2006512364 A5 JP 2006512364A5
Authority
JP
Japan
Prior art keywords
solvate
pharmaceutically acceptable
acceptable salt
compound
warm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004562206A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006512364A (ja
Filing date
Publication date
Priority claimed from SE0203820A external-priority patent/SE0203820D0/xx
Application filed filed Critical
Publication of JP2006512364A publication Critical patent/JP2006512364A/ja
Publication of JP2006512364A5 publication Critical patent/JP2006512364A5/ja
Pending legal-status Critical Current

Links

JP2004562206A 2002-12-20 2003-12-18 ケモカイン受容体ｃｃｒ５のモジュレーターとしての新規ピペリジン誘導体 Pending JP2006512364A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0203820A SE0203820D0 (sv) 2002-12-20 2002-12-20 chemical compounds
PCT/SE2003/002005 WO2004056808A1 (en) 2002-12-20 2003-12-18 Novel piperidine derivatives as modulators of chemokine receptor ccr5

Publications (2)

Publication Number Publication Date
JP2006512364A JP2006512364A (ja) 2006-04-13
JP2006512364A5 true JP2006512364A5 (https=) 2007-02-08

Family

ID=20289969

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004562206A Pending JP2006512364A (ja) 2002-12-20 2003-12-18 ケモカイン受容体ｃｃｒ５のモジュレーターとしての新規ピペリジン誘導体

Country Status (9)

Country Link
US (1) US20060069120A1 (https=)
EP (1) EP1572683B1 (https=)
JP (1) JP2006512364A (https=)
AT (1) ATE342898T1 (https=)
AU (1) AU2003288853A1 (https=)
DE (1) DE60309206T2 (https=)
ES (1) ES2274295T3 (https=)
SE (1) SE0203820D0 (https=)
WO (1) WO2004056808A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
TW200610761A (en) * 2004-04-23 2006-04-01 Astrazeneca Ab Chemical compounds
SE0401656D0 (sv) * 2004-06-24 2004-06-24 Astrazeneca Ab Chemical compounds
BRPI0810411B8 (pt) * 2007-04-18 2021-05-25 Pfizer Prod Inc derivados de sulfonil amida para o tratamento de crescimento celular anormal, seu sos, bem como composição farmacêutica
CN102131779A (zh) * 2008-09-01 2011-07-20 神经研究公司 哌啶-4-乙酰胺衍生物及其作为单胺神经递质再摄取抑制剂的应用
MX2011001847A (es) * 2008-09-01 2011-04-04 Neurosearch As Nuevos derivados de piperidina-propionamida y su uso como inhibidores de la reabsorcion del neurotransmisor de monoamina.
SG181900A1 (en) 2009-12-23 2012-08-30 Ironwood Pharmaceuticals Inc Crth2 modulators
CN102241664B (zh) * 2010-05-13 2014-11-12 上海医药工业研究院 芳烷二胺类衍生物及其作为抗抑郁症药物的应用
WO2012009134A1 (en) 2010-07-12 2012-01-19 Ironwood Pharmaceuticals, Inc. Crth2 modulators
US20130216552A1 (en) 2010-07-12 2013-08-22 Ironwood Pharmaceuticals, Inc. Crth2 modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL125658A0 (en) * 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
EP1013276A1 (en) * 1998-12-23 2000-06-28 Pfizer Inc. Aminoazacycloalkanes as CCR5 modulators
GB0011838D0 (en) * 2000-05-17 2000-07-05 Astrazeneca Ab Chemical compounds
GB0013060D0 (en) * 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
GB0108046D0 (en) * 2001-03-30 2001-05-23 Astrazeneca Ab Chemical compounds

Similar Documents

Publication Publication Date Title
JP6907173B2 (ja) スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用
US10577337B2 (en) Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof
TW202341983A (zh) 用於降解突變kras蛋白之化合物及其應用
JP5815746B2 (ja) Ｃ型肝炎ウイルス阻害剤
NO20064151L (no) Nye forbindelser
ES2728199T3 (es) Indazoles sustituidos con amida como inhibidores de poli (ADP-ribosa) polimerasa (PARP)
RU2009135621A (ru) Хинолиновые производные для лечения воспалительных заболеваний
TW201245149A (en) Processes and intermediates
EA033626B1 (ru) АМИНОЗАМЕЩЕННЫЕ ИМИДАЗО[1,2-а]ПИРИДИНКАРБОКСАМИДЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ, ИХ ПРИМЕНЕНИЕ И ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ ИХ
JP2006524662A5 (https=)
TW200840568A (en) Novel diamide derivative
CZ287610B6 (cs) Pentanamidové deriváty a farmaceutický prostředek s jejich obsahem
JP2006512364A5 (https=)
JP2018509441A (ja) 水溶性プロドラッグ
JP2004525183A5 (https=)
US11634428B2 (en) Deuterated angiotensin-converting enzyme-2 (ACE-2) inhibitors
RU2005131735A (ru) Химические соединения
US6545008B1 (en) Pyrimidine derivatives and processes for the preparation thereof
FR3050732B1 (fr) Nouveaux derives de phosphinolactones et leurs utilisations pharmaceutiques
CA2534003A1 (en) 3-quinuclidinyl-n-biarylamides as nicotinic acetylcholine receptor agonists
RU2007102272A (ru) Замещенные дикетопиперазины в качестве антагонистов
EP4649086A1 (en) Protease inhibitors for treating or preventing coronavirus infection
AU2023385361A1 (en) 2-amino-n-(4-amino-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butan-2-yl)benzamide derivatives as protease inhibitors for treating or preventing coronavirus infection
TWI570119B (zh) （２ｓ）－３－［（３ｓ，４ｓ）－３－［（１ｒ）－１－羥乙基］－４－（４－甲氧基－３－｛［１－（５－甲基吡啶－２－基）吖丁啶－３－基］氧基｝苯基）－３－甲基吡咯啶－１－基］－３－氧代丙烷－１，２－二醇結晶型及其用途
JP2022533943A (ja) Ａｂｈｄ１２阻害剤並びにその作製及び使用方法